Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

416 public trials 60 recruiting studies

Leukemia, Myelomonocytic, Chronic trial results

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 13 locations
Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +25 more
Locations
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • University of Oklahoma Oklahoma City, Oklahoma, United States
Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Sendai, Miyagi, Japan